NCT03690726

Brief Summary

The project will investigate whether repetitive transcranial magnetic stimulation (rTMS) can be used to potentiate/prime spinal cord injured patients' nervous systems for more intense rehabilitation exercise of longer duration - thus leading to greater recovery of motion function. The technique, in which a magnetic coil is positioned above the scalp and forms a magnetic field that activates the desired center of the brain (eg motor cortex), is used in clinical practice for the treatment of a number of disorders. However, although a combination of rTMS and gait training in SCI patients previously has proven beneficial, it is unknown whether additional functional gains can be achieved by combining rTMS and supervised, high-intensity resistance training. In this project, 30 newly-admitted patients will be recruited and randomized to receive either active rTMS and strength training (n = 15) or sham (imitated) rTMS + strength training, in parallel with standard care. The investigators hypothesize that the active rTMS group will have superior gains in locomotor function and muscle mass, compared to the sham group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 1, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

January 2, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

December 29, 2020

Status Verified

December 1, 2020

Enrollment Period

1.6 years

First QC Date

September 20, 2018

Last Update Submit

December 28, 2020

Conditions

Outcome Measures

Primary Outcomes (5)

  • 6 minutes walking test

    Test of ambulatory endurance. It measures the maximal distance covered within 6 minutes.

    Measures the change from baseline and after 8 weeks of intervention

  • Lower limb maximal muscle strength

    Measures the maximal voluntary contraction torque of the knee flexors and knee extensors.

    Measures the change from baseline and after 8 weeks of intervention

  • Timed up and go test

    Measures the time (in seconds) it takes a person to get up from an ordinary chair with back and armrest, walk 3 meters, turn back to the chair and sit back.

    Measures the change from baseline and after 8 weeks of intervention

  • Rate of force development

    Measures the explosive muscle force of the knee flexors and knee extensors.

    Measures the change from baseline and after 8 weeks of intervention

  • 10 meter walking test

    Measures the time (in seconds) it takes to cover 10 meters during level-ground walking.

    Measures the change from baseline and after 8 weeks of intervention

Secondary Outcomes (7)

  • Quantitative Sensory Testing

    Measures the change from baseline and after 8 weeks of intervention

  • H-reflex test

    Measures the change from baseline and after 8 weeks of intervention

  • Modified Ashworth Scale

    Measures the change from baseline and after 8 weeks of intervention

  • The International Standards for Neurological Classification of Spinal Cord Injury

    Measures the change from baseline and after 8 weeks of intervention

  • Walking Index for Spinal Cord Injury test

    Measures the change from baseline and after 8 weeks of intervention

  • +2 more secondary outcomes

Study Arms (2)

Active rTMS

EXPERIMENTAL

SCI patients fulfilling criteria for participation giving informed written and verbal consent, who are enrolled and randomised to active treatment arm receive consecutive treatment sessions with rTMS directed at cranium and cortex regions as described in protocol.

Device: repetitive transcranial magnetic stimulation

Sham rTMS

SHAM COMPARATOR

SCI patients fulfilling criteria for participation giving informed written and verbal consent, who are enrolled and randomised to sham/control arm receive consecutive treatment sessions with coil from rTMS that fires at other spot (pillow/mattress) as described in protocol.

Other: Sham stimulation

Interventions

Repetitive transcranial magnetic stimulation of the leg motor cortex, in combination with resistance training

Active rTMS

Imitated magnetic stimulation: An active coil will be activated under the subject's head, firing down into the mattress, while an inactive coil will be held over the scalp

Sham rTMS

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • sub-acute (\<6 months) incomplete spinal cord injury
  • admitted at the SCIWDK for primary rehabilitation

You may not qualify if:

  • Medical history of multiple central nervous system lesions,
  • severe structural,
  • inflammatory or degenerative cerebral disorders,
  • epilepsy,
  • other neurological diseases,
  • lower limb peripheral injury,
  • or orthopedic injuries that may limit maximal effort contractions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spinal Cord Injury Centre of Western Denmark

Viborg, 8800, Denmark

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Helge Kasch, MD, PhD

    Spinal Cord Injury Centre of Western Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Placebo Controlled Clinical Intervention Study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Research Director, Associate Professor, Clinical Neurology, MD, PhD

Study Record Dates

First Submitted

September 20, 2018

First Posted

October 1, 2018

Study Start

January 2, 2019

Primary Completion

August 1, 2020

Study Completion

August 1, 2020

Last Updated

December 29, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations